+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Prurigo Nodularis - Pipeline Insight, 2025 - Product Thumbnail Image

Prurigo Nodularis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Psoriasis Vulgaris- Pipeline Insight, 2025 - Product Thumbnail Image

Psoriasis Vulgaris- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Recurrent Herpes Labialis - Pipeline Insight, 2025 - Product Thumbnail Image

Recurrent Herpes Labialis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Stargardt Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Stargardt Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Sudden Sensorineural Hearing Loss (SSNHL) - Pipeline Insight, 2025 - Product Thumbnail Image

Sudden Sensorineural Hearing Loss (SSNHL) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Tuberous Sclerosis Complex - Pipeline Insight, 2025 - Product Thumbnail Image

Tuberous Sclerosis Complex - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Usher Syndrome Type 2 - Pipeline Insight, 2025 - Product Thumbnail Image

Usher Syndrome Type 2 - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Visceral Pain Associated With GI Disorders - Pipeline Insight, 2025 - Product Thumbnail Image

Visceral Pain Associated With GI Disorders - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
X-Linked Myotubular Myopathy (XLMTM) - Pipeline Insight, 2025 - Product Thumbnail Image

X-Linked Myotubular Myopathy (XLMTM) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Charcot Marie Tooth Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Charcot Marie Tooth Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Lipodystrophy Syndrome (LS) - Pipeline Insight, 2025 - Product Thumbnail Image

Lipodystrophy Syndrome (LS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Macular Edema - Pipeline Insight, 2025 - Product Thumbnail Image

Macular Edema - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mastocytosis - Pipeline Insight, 2025 - Product Thumbnail Image

Mastocytosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Memory Disorders - Pipeline Insight, 2025 - Product Thumbnail Image

Memory Disorders - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mitochondrial Myopathies- Pipeline Insight, 2025 - Product Thumbnail Image

Mitochondrial Myopathies- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mitral Valve Insufficiency - Pipeline Insight, 2025 - Product Thumbnail Image

Mitral Valve Insufficiency - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Molybdenum Cofactor Deficiency (MOCOD)emerging - Pipeline Insight, 2025 - Product Thumbnail Image

Molybdenum Cofactor Deficiency (MOCOD)emerging - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mucopolysaccharidosis II - Pipeline Insight, 2025 - Product Thumbnail Image

Mucopolysaccharidosis II - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Multi-Drug-Resistant (MDR) Neisseria Gonorrhoeae - Pipeline Insight, 2025 - Product Thumbnail Image

Multi-Drug-Resistant (MDR) Neisseria Gonorrhoeae - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Idiopathic CD4+ Lymphocytopenia - Pipeline Insight, 2025 - Product Thumbnail Image

Idiopathic CD4+ Lymphocytopenia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more